Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Insider Changes in Ownership
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. EFFECT Other Notice of Effectiveness
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. 4 Insider Changes in Ownership
  9. 3 Insider Initial Statement of Ownership
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 8-K Event Executive or director change
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 8-K Event Regulation FD disclosure
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 2 of 67 · 1,337 filings